Haemonetics Corp (HAE) - Financial and Strategic SWOT Analysis Review

Region:North America

Author(s):

Product Code:GDME707FSA

Download Sample Report download
Buy the Full ReportStarting from $125
Published on

August 2018

Total pages

56

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $125

About the Report

About the Report

Haemonetics Corp (HAE)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Haemonetics Corp (Haemonetics) is a healthcare company that offers blood management technologies and software solutions. Its portfolio includes integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehensive suite of solutions to the blood supply chain, which ranges from plasma and blood collectors to hospitals. Haemonetics markets its products to blood collection groups and independent blood centers, national health organizations, hospital service providers, hospitals, group purchasing organizations, and bio-pharmaceutical companies through a direct sales force and independent distributors. It has subsidiaries in the Americas, Asia and Europe. Haemonetics is headquartered in Braintree, Massachusetts, the US.

Haemonetics Corp Key Recent Developments

May 08,2018: Haemonetics Appoints Said Bolorforosh Executive Vice President, Chief Technology Officer

May 08,2018: Haemonetics Reports 4th Quarter and Fiscal Year 2018 Results and Provides Fiscal 2019 Guidance

Feb 06,2018: Haemonetics 3rd Quarter Fiscal 2018 Earnings

Jan 25,2018: Ellen M. Zane Rejoins Haemonetics Board of Directors

Oct 18,2017: Robert E. Abernathy Joins Haemonetics Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Products

Products

Haemonetics Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Fresenius Medical Care AG & Co KGaA

Hamilton Thorne Ltd

LivaNova PLC

MAK Technologies

Medtronic Plc

Rotem

Terumo BCT Inc

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Haemonetics Corp-Key Facts 6

Haemonetics Corp-Key Employees 7

Haemonetics Corp-Key Employee Biographies 8

Haemonetics Corp-Major Products and Services 9

Haemonetics Corp-History 12

Haemonetics Corp-Company Statement 15

Haemonetics Corp-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Section 2-Company Analysis 20

Company Overview 20

Haemonetics Corp-Business Description 21

Product Category: Blood Center 21

Overview 21

Performance 21

Product Category: Cell Processing 22

Overview 22

Performance 22

Product Category: Hemostasis Management 22

Overview 22

Performance 22

Product Category: Plasma 23

Overview 23

Performance 23

Product Category: All Other 23

Performance 23

Product Category: EMEA 23

Performance 23

Product Category: Japan 24

Performance 24

Product Category: North America Plasma 24

Performance 24

Geographical Segment: Asia 24

Performance 24

Geographical Segment: Europe 24

Performance 24

Geographical Segment: Japan 24

Performance 24

Geographical Segment: Other 24

Performance 24

Geographical Segment: The US 25

Performance 25

Haemonetics Corp-Corporate Strategy 26

Haemonetics Corp-SWOT Analysis 27

SWOT Analysis-Overview 27

Haemonetics Corp-Strengths 27

Haemonetics Corp-Weaknesses 28

Haemonetics Corp-Opportunities 29

Haemonetics Corp-Threats 30

Haemonetics Corp-Key Competitors 31

Section 3-Company Financial Ratios 32

Financial Ratios-Capital Market Ratios 32

Financial Ratios-Annual Ratios 33

Performance Chart 36

Financial Performance 36

Financial Ratios-Interim Ratios 37

Financial Ratios-Ratio Charts 38

Section 4-Company's Lifesciences Financial Deals and Alliances 39

Haemonetics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 39

Haemonetics Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 40

Haemonetics Corp, Recent Deals Summary 41

Section 5-Company's Recent Developments 42

May 08, 2018: Haemonetics Appoints Said Bolorforosh Executive Vice President, Chief Technology Officer 42

May 08, 2018: Haemonetics Reports 4th Quarter and Fiscal Year 2018 Results and Provides Fiscal 2019 Guidance 43

Feb 06, 2018: Haemonetics 3rd Quarter Fiscal 2018 Earnings 45

Jan 25, 2018: Ellen M. Zane Rejoins Haemonetics Board of Directors 47

Oct 18, 2017: Robert E. Abernathy Joins Haemonetics Board of Directors 48

Jun 22, 2017: Haemonetics Announces Formation of Scientific Advisory Council 49

May 08, 2017: Haemonetics Reports 4th Quarter and Fiscal Year 2017 Results and Provides Fiscal 2018 Guidance 50

Section 6-Appendix 52

Methodology 52

Ratio Definitions 52

About GlobalData 56

Contact Us 56

Disclaimer 56


List of Figure

List of Figures

Haemonetics Corp, Performance Chart (2014-2018) 36

Haemonetics Corp, Ratio Charts 38

Haemonetics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 39

Haemonetics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 40


List of Table

List of Tables

Haemonetics Corp, Key Facts 6

Haemonetics Corp, Key Employees 7

Haemonetics Corp, Key Employee Biographies 8

Haemonetics Corp, Major Products and Services 9

Haemonetics Corp, History 12

Haemonetics Corp, Other Locations 17

Haemonetics Corp, Subsidiaries 18

Haemonetics Corp, Key Competitors 31

Haemonetics Corp, Ratios based on current share price 32

Haemonetics Corp, Annual Ratios 33

Haemonetics Corp, Annual Ratios (Cont...1) 34

Haemonetics Corp, Annual Ratios (Cont...2) 35

Haemonetics Corp, Interim Ratios 37

Haemonetics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 39

Haemonetics Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 40

Haemonetics Corp, Recent Deals Summary 41

Currency Codes 52

Capital Market Ratios 52

Equity Ratios 53

Profitability Ratios 53

Cost Ratios 54

Liquidity Ratios 54

Leverage Ratios 55

Efficiency Ratios 55

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022